Cargando…

Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model

BACKGROUND: Cirrhosis is a long-term consequence of chronic hepatic injury with fibrosis. No effective therapy is currently available for decompensated cirrhosis except liver transplantation. Hence, we investigated the effect of bone marrow-derived mesenchymal stem cells (BM-MSCs) on hepatic fibrosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Yoon Ok, Kim, Moon Young, Cho, Mee Yon, Baik, Soon Koo, Cho, Youn Zoo, Kwon, Sang Ok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251876/
https://www.ncbi.nlm.nih.gov/pubmed/25425284
http://dx.doi.org/10.1186/s12876-014-0198-6
_version_ 1782347106626830336
author Jang, Yoon Ok
Kim, Moon Young
Cho, Mee Yon
Baik, Soon Koo
Cho, Youn Zoo
Kwon, Sang Ok
author_facet Jang, Yoon Ok
Kim, Moon Young
Cho, Mee Yon
Baik, Soon Koo
Cho, Youn Zoo
Kwon, Sang Ok
author_sort Jang, Yoon Ok
collection PubMed
description BACKGROUND: Cirrhosis is a long-term consequence of chronic hepatic injury with fibrosis. No effective therapy is currently available for decompensated cirrhosis except liver transplantation. Hence, we investigated the effect of bone marrow-derived mesenchymal stem cells (BM-MSCs) on hepatic fibrosis in a thioacetamide (TAA)-induced cirrhotic rat model. METHODS: The BM-MSCs were injected directly into the right liver lobe twice, at 6 and 8 weeks during the 12-week TAA administration, in thioacetamide (TAA)-induced cirrhotic rats model, and hepatic fibrosis was evaluated. At 12 weeks, the effect of BM-MSCs on hepatic fibrosis was analyzed histomorphologically using the Laennec fibrosis scoring system, and the collagen proportionate area was quantified. Cirrhosis-related factors, such as transforming growth factor β1 (TGF-β1), type 1 collagen (collagen-1), α-smooth muscle actin (α-SMA), and P-Smad3/Smad3 expression levels, were evaluated using real-time polymerase chain reaction and western blot assays. RESULTS: According to the Laennec fibrosis scoring system, histological improvement was observed in hepatic fibrosis after BM-MSC treatment (P <0.01). The percentage of the collagen proportionate area decreased from 16.72 ± 5.51 to 5.06 ± 1.27 after BM-MSC treatment (P <0.01). The content of hepatic hydroxyproline was significantly lower in the BM-MSC treated group (46.25 ± 13.19) compared to the untreated cirrhotic group (85.81 ± 17.62; P <0.01). BM-MSC administration significantly decreased TGF-β1, collagen-1, and α-SMA expression in TAA-induced cirrhotic rats (P <0.01). We also confirmed P-Smad3/Smad3, downstream effectors of the TGF-β1 signaling pathway, and found that MSC transplantation inhibited Smad3 phosphorylation. CONCLUSIONS: BM-MSC treatment attenuated hepatic fibrosis in rats with TAA-induced cirrhosis, raising the possibility of the clinical use of BM-MSCs in the treatment of cirrhosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12876-014-0198-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4251876
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42518762014-12-03 Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model Jang, Yoon Ok Kim, Moon Young Cho, Mee Yon Baik, Soon Koo Cho, Youn Zoo Kwon, Sang Ok BMC Gastroenterol Research Article BACKGROUND: Cirrhosis is a long-term consequence of chronic hepatic injury with fibrosis. No effective therapy is currently available for decompensated cirrhosis except liver transplantation. Hence, we investigated the effect of bone marrow-derived mesenchymal stem cells (BM-MSCs) on hepatic fibrosis in a thioacetamide (TAA)-induced cirrhotic rat model. METHODS: The BM-MSCs were injected directly into the right liver lobe twice, at 6 and 8 weeks during the 12-week TAA administration, in thioacetamide (TAA)-induced cirrhotic rats model, and hepatic fibrosis was evaluated. At 12 weeks, the effect of BM-MSCs on hepatic fibrosis was analyzed histomorphologically using the Laennec fibrosis scoring system, and the collagen proportionate area was quantified. Cirrhosis-related factors, such as transforming growth factor β1 (TGF-β1), type 1 collagen (collagen-1), α-smooth muscle actin (α-SMA), and P-Smad3/Smad3 expression levels, were evaluated using real-time polymerase chain reaction and western blot assays. RESULTS: According to the Laennec fibrosis scoring system, histological improvement was observed in hepatic fibrosis after BM-MSC treatment (P <0.01). The percentage of the collagen proportionate area decreased from 16.72 ± 5.51 to 5.06 ± 1.27 after BM-MSC treatment (P <0.01). The content of hepatic hydroxyproline was significantly lower in the BM-MSC treated group (46.25 ± 13.19) compared to the untreated cirrhotic group (85.81 ± 17.62; P <0.01). BM-MSC administration significantly decreased TGF-β1, collagen-1, and α-SMA expression in TAA-induced cirrhotic rats (P <0.01). We also confirmed P-Smad3/Smad3, downstream effectors of the TGF-β1 signaling pathway, and found that MSC transplantation inhibited Smad3 phosphorylation. CONCLUSIONS: BM-MSC treatment attenuated hepatic fibrosis in rats with TAA-induced cirrhosis, raising the possibility of the clinical use of BM-MSCs in the treatment of cirrhosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12876-014-0198-6) contains supplementary material, which is available to authorized users. BioMed Central 2014-11-25 /pmc/articles/PMC4251876/ /pubmed/25425284 http://dx.doi.org/10.1186/s12876-014-0198-6 Text en © Jang et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Jang, Yoon Ok
Kim, Moon Young
Cho, Mee Yon
Baik, Soon Koo
Cho, Youn Zoo
Kwon, Sang Ok
Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model
title Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model
title_full Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model
title_fullStr Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model
title_full_unstemmed Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model
title_short Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model
title_sort effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251876/
https://www.ncbi.nlm.nih.gov/pubmed/25425284
http://dx.doi.org/10.1186/s12876-014-0198-6
work_keys_str_mv AT jangyoonok effectofbonemarrowderivedmesenchymalstemcellsonhepaticfibrosisinathioacetamideinducedcirrhoticratmodel
AT kimmoonyoung effectofbonemarrowderivedmesenchymalstemcellsonhepaticfibrosisinathioacetamideinducedcirrhoticratmodel
AT chomeeyon effectofbonemarrowderivedmesenchymalstemcellsonhepaticfibrosisinathioacetamideinducedcirrhoticratmodel
AT baiksoonkoo effectofbonemarrowderivedmesenchymalstemcellsonhepaticfibrosisinathioacetamideinducedcirrhoticratmodel
AT choyounzoo effectofbonemarrowderivedmesenchymalstemcellsonhepaticfibrosisinathioacetamideinducedcirrhoticratmodel
AT kwonsangok effectofbonemarrowderivedmesenchymalstemcellsonhepaticfibrosisinathioacetamideinducedcirrhoticratmodel